GE HealthCare has expanded its partnership with RadNet subsidiary DeepHealth to broaden access to AI-powered breast cancer screening solutions.
The agreement builds upon a collaboration first announced in 2024, which integrated DeepHealth’s AI screening workflow with GE HealthCare’s Senographe Pristina mammography system.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Together, these technologies aim to improve image interpretation and operational efficiency.
The new phase will extend their joint offerings internationally, incorporating a second reader workflow and broadening access to DeepHealth’s cancer screening components.
As DeepHealth’s Breast Suite solution expands, GE HealthCare now provides a modular, cloud-based suite that integrates smoothly with current breast imaging operations.
Combined with Pristina Via, the collaborative solution supports scalable screening.
The Breast Suite includes a cloud-first viewer, AI-based cancer detection, density assessment, prioritised worklists, timely alerts, and enhanced reporting.
The collaboration sees GE HealthCare extend the distribution of new Breast Suite applications tailored for their systems, including ProFound Pro (AI-based lesion detection and density assessment) and Safeguard Review (optional workflow for complex case review).
GE HealthCare Women’s Health and X-ray president and CEO Jyoti Gupta said: “At GE HealthCare, we’re advancing women’s health through precision care built around the unique needs of women and enhanced by the power of AI.
“By integrating Breast Suite AI with our Pristina Via mammography system, we’re helping clinicians detect breast cancer early with greater confidence. These innovations move us closer towards truly personalised prevention and care for women.”
Earlier this month, GE HealthCare integrated its bkActiv intraoperative ultrasound (iUS) system with Medtronic’s Stealth AXiS surgical navigation system to provide imaging during cranial procedures.